Post-licensure safety study of new-onset immune-mediated diseases, herpes zoster, and anaphylaxis in adult recipients of HepB-CpG vaccine versus HepB-alum vaccine
CONCLUSIONS: This large post-licensure study did not identify evidence of safety concerns for HepB-CpG compared to HepB-alum for immune-mediated diseases, HZ, or anaphylaxis.PMID:37308363 | DOI:10.1016/j.vaccine.2023.06.004
Source: Vaccine - Category: Allergy & Immunology Authors: Bradley Ackerson Lina S Sy Jeff Slezak Lei Qian Kristi Reynolds Runxin Huang Zendi Solano William Towner Sijia Qiu Sarah R Simmons Steven J Jacobsen Katia J Bruxvoort Source Type: research
More News: Allergy & Immunology | Anaphylactic Shock | Arthritis | Dialysis | Electronic Health Records (EHR) | Hepatitis | Hepatitis B | Hepatitis Vaccine | Herpes | Rheumatoid Arthritis | Rheumatology | Shingles (Herpes Zoster) Vaccine | Statistics | Study | Vaccines | Varicella-Zoster Virus Vaccine